AMGN - AMGEN INC
IEX Last Trade
261.8
-0.210 -0.080%
Share volume: 76,238
Last Updated: Tue 07 Jan 2025 08:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.90%
PREVIOUS CLOSE
CHG
CHG%
$262.01
-0.21
-0.08%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-04-28 | 2023-08-04 | 2023-10-31 | 2024-02-14 | 2024-05-03 | |
| Total revenue | 6.105 B | 6.986 B | 6.903 B | 8.196 B | 7.447 B | |
| Cost of revenue | 1.720 B | 1.813 B | 1.806 B | 3.112 B | 3.200 B | |
| Gross profit | 4.385 B | 5.173 B | 5.097 B | 5.084 B | 4.247 B | |
| 17.97% | -1.47% | -0.26% | -16.46% | |||
| Operating expenses | 2.316 B | 2.407 B | 2.432 B | 3.808 B | 3.151 B | |
| Selling general and admin | 1.258 B | 1.294 B | 1.353 B | 2.274 B | 1.808 B | |
| Research and development | 1.058 B | 1.113 B | 1.079 B | 1.534 B | 1.343 B | |
| Total expenses | 4.036 B | 4.220 B | 4.882 B | 7.155 B | 6.456 B | |
| 4.56% | 15.69% | 46.56% | -9.77% | |||
| Operating income | 2.069 B | 2.766 B | 2.021 B | 1.041 B | 991.000 M | |
| Ebit | 1.921 B | 2.684 B | 2.021 B | 1.271 B | 991.000 M | |
| Pretax income | 3.442 B | 1.614 B | 1.947 B | 852.000 M | -68.000 M | |
| -53.11% | 20.63% | -56.24% | -107.98% | |||
| Income tax | 601.000 M | 235.000 M | 217.000 M | 85.000 M | 45.000 M | |
| Net income basic | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | |
| -51.46% | 25.45% | -55.66% | -114.73% | |||
| Net income | 2.841 B | 1.379 B | 1.730 B | 767.000 M | -113.000 M | |
| -51.46% | 25.45% | -55.66% | -114.73% |